Abstract
Historically, erectile dysfunction (ED), as all sexual dysfunctions, has been relegated to a lower priority in a busy primary care practice. However, it is becoming evident that ED will not only accompany disease states of high comorbidity, but also can serve as an early marker for some patients presenting without established cardiovascular disease. What follows is an examination of trends of sexual inquiry in primary care practice and why asking about erectile dysfunction should be vital; how to engage a patient to allow for such a discussion; the workup, treatment, and determination of organic erectile dysfunction; how to manage the nonresponder to PDE5i therapy; and when to refer. It is the hope of the authors that sexual inquiry can become standard in primary care practice. The number of men with ED is increasing by the decade, and it is vital to propose both a workup and a treatment plan, that is, not only simple but also includes basic lifestyle changes that address diet and exercise. The chapter will include the optimization of PDE5i therapy, and will review other pharmacologic and surgical therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lamberts H, Hofmans-Okkes I. Values and roles in primary care. J Fam Pract. 1996;42:178–80.
Stafford RS, Saglam D, Causino N, et al. Trends in adult visits to primary care physicians in the United States. Arch Fam Med. 1999;8:26–32.
Blumenthal D, Causino N, Chang YC, et al. The duration of ambulatory visits to physicians. J Fam Pract. 1999;48:264–71.
Bullough VL. American physicians and sex research and expertise 1900–1990. J Hist Med. 1997;52:236–53.
Broekman CPM, Van Der Werf T, Bosch JJ, Slob AK. An investigation into the management of patients with erection problems in general practice. Int J Impot Res. 1994;6:67–72.
Becker BL. Streamlined office management. Article consultant: Baum N, Patient Care Supplement Spring 1999; 17–21.
Herrick P. Problems in human sexuality encountered in primary care. PA J. 1976;6(1):3–10.
Stine CC, Collins M. Male sexual dysfunction. Prim Care. 1989;16:1031–56.
Hakim J, Subit M, Maroon M. Screening for erectile dysfunction in the primary care practice: results of a survey. W V Med J. 2005;101:67–70.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.
Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res. 2003;15:63–71.
Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of prevalence and need for healthcare in the general population. Fam Pract. 1998;15:519–24.
Jonler M, Moon T, Branaan W, et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol. 1995;75:651–5.
Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: a cross-sectional population survey. J Epidemiol Community Health. 1999;53:144–8.
Anderson MA, Mulhall JP. Epidemiology of erectile dysfunction. In: Mulcahy JJ, editor. Male sexual function. New York: Igaku-shoin; 2001. First Edition.
McVary KT, Carrier S, Wessells H. Smoking and erectile dysfunction. J Urol. 2001;166:1624–32.
Seftel A, Rosen R, Kuritzky L. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications. Int J Impot Res. 2007;19(4):386–92.
Weeks GR, Gambescia N. Erectile dysfunction: integrating couples therapy, sex therapy, and medical treatment. New York: WW Norton and Co; 2000. p. 43–4.
Sadovsky R, Miner M. Erectile dysfunction is a signal of risk for cardiovascular disease: a primary care view. Prim Care Clin Office Pract. 2005;32:977–93.
Curkendall SM, Jones JK, Glasser D, et al. Incidence of medically detected erectile dysfunction and related diseases before and after Viagra (sildenafil citrate). Eur Urol. 1998;37 Suppl 2:81.
DeWire DM. Evaluation and treatment of ED. Am Fam Phys. 1996;53:2102–7.
Billups K, Fiedrich S. Assessment of fasting lipid panels and Doppler ultrasound testing in men presenting with erectile dysfunction and no other medical problems. J Urol. 2000;163:147.
Roumeguere T, Wespes E, Carpentier Y, et al. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol. 2003;44:355–9.
Grover SA, Lowensteyn I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting. Arch Intern Med. 2006;166:213–9.
Gaigal CS, Wessels H, Pace J, et al. Predictors and prevalence of erectile dysfunction ion in men referred for nuclear stress testing. Arch Intern Med. 2006;166:201–6.
Min JK, Williams KA, Okwuosa TM, et al. Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing. Arch Intern Med. 2006;166:201–6.
Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002.
Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J. 2006;27(22):2632–9.
Sadovsky R, Mulhall J. The potential value of ED inquiry and management. IJCP. 2003;57:601–8.
Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med. 2005;2:40–52.
Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep. 2002;2:501–9.
Halcox JP, Schenjke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–8.
Banks J, Marmot M, Oldfield Z, Simith JP. Disease and disadvantage in the United States and England. JAMA. 2006;295:2037–45.
Young SE, Mainous AG, Diaz VA, Everett C. Practice patterns in sildenafil prescribing. Fam Med. 2006;38(2):110–5.
Holmes TH, Rahe RH. Social adjustment rating scale. J Psychosom Res. 1967;11:213–8.
Birchler GR, Webb LJ. Discriminating interactive behavior in happy and unhappy marriages. J Consult Clin Psychol. 1977;45:494–5.
Gott M, Galena E, Hinchiff S, Elford M. “Opening a can of worms”: GP and practice nurse barriers to talking about sexual health in primary care. Fam Pract. 2004;21:528–36.
Nusbaum MR, Gamble G, Heiman J. The high prevalence of sexual concerns among women seeking routine gynecological care. J Fam Pract. 2000;49:229–32.
Ackerman MD, Carey MP. Psychology’s role in the assessment of sexual dysfunction: historical precedents, current knowledge, and methods. J Consult Clin Psychol. 1995;63:862–76.
Dunn MR. Restoration of couple’s intimacy and relationship visits to reestablishing erectile function. JAOA. 2004;104 Suppl 4:S6–10.
Gregoire A. Assessing and managing male sexual problems. West J Med. 2000;172:49–50.
Sadovsky R. The role of the primary care clinician in the management of erectile dysfunction. Rev Urol. 2002;4 Suppl 3:S54–63.
Tudiver F, Talbot Y. Why don’t men seek help? Family physicians’ perspectives on help-seeking behavior in men. J Fam Pract. 1999;48:47–52.
Courtenay WH. Constructions of masculinity and their influence on men’s well being: a theory of gender and health. Soc Sci Med. 2000;50:1385–401.
Penson D, Kreiger JN. Men’s health. Are we missing the big picture? JGIM. 2001;16:717–8.
Nusbaum MRH. Sexual Health. AAFP home study assessment program 2001. Monograph 267:9.
Laumann E. The social organization of sexuality: sexual practices in the United States 1994. Chicago: University of Chicago Press; 1994.
DeBerardis G, Franciosi M, Belfigilio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients. Diabetes Care. 2002;25:284–91.
Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000;56:302–6.
Pinnock CB, Stapleton AMF, Marshal VR. Erectile dysfunction in the community: a prevalence study. Med J Aust. 1999;171:353–7.
Esposito K, Giugliano R, DiPalo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men. JAMA. 2004;291:2978–84.
Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347:1941–51.
Latshcer F. The human costs of tobacco use. (editorial). N Engl J Med. 1994;331:618.
Jeremy JY, Mikhailidis DP. Cigarette smoking and erectile dysfucntion. J R Soc Health. 1998;118:151–5.
Kuritzky L. Counseling the patient with erectile dysfunction: a primary care physician perspective. JAOA. 2002;102 Suppl 4:S7–11.
Halvorson JG. The clinical evaluation of common sexual concerns. CNS Spectrum. 2003;8(3):217–24.
Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinic outpatients. JAMA. 1983;249:1736–40.
Finfer WW, Lung M, Stagle MA. Medications that may contribute to sexual disorders. J Fam Pract. 1997;44:33–43.
Muller JE, Mittleman MA, Maclure M, et al. Triggering myocardial infarction by sexual activity. JAMA. 1996;275:1405–9.
Lue TF. Impotence: patient’s goal-directed approach to treatment. World J Urol. 1990;8:67–74.
Althof SE, Seftel AD. The evaluation and management of erectile dysfunction. Psychiatr Clin North Am. 1995;18:171–92.
McLaughlin SP, Carson CC. Laboratory evaluation of the patient with erectile dysfunction. Endocrine. 2004;23:113–7.
Barrett-Connor E. Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction. Clin Card. 2004;27 Suppl 4:8–13.
Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96:85–93.
Sadovsky R. Erectile dysfunction is a signal of risk for significant medical comorbidities: a primary care view. Curr Sex Health Rep. 2004;1:129–36.
Aruajo AB, Durante R, Feldman HA, et al. The relationship between depressive symptoms and male erectile dysfunction. Cross-sectional results from the Massachusetts male Aging Study. Psychosomatic Med. 1998;60:458–65.
Anderson MA, Mulhall JP. Epidemiology of erectile dysfunction. In: Mulcahy JJ, editor. Male sexual function. New York: Igaku-shoin; 2001. p. 1–11.
Van der Kooy K, van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular disease: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007;22:613–26.
Spertus JA, McDonell M, Woodman CL, Fihn SD. Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am Heart J. 2000;140(1):105–10.
Ruo B, Rumsfeld JS, Hlaky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003;290(2):215–21.
Screening for Coronary Heart Disease. Recommendaiton Statement. U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:569–72.
Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.
Zoler ML. Erectile dysfunction may presage vascular dysfunction. Family Practice News. 2004;40
Mosher D. Sex guilt and sex myths in college men and women. J Sex Res. 1979;15:224–34.
Blumstein P, Schwartz P. American couples: money, work, and sex. New York: William Morrow; 1983.
Sprecher S, McKinney K. Sexuality. Newbury Park: Sage; 1993.
Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–7.
Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342:454–60.
Gokce N, Vita JA, Bader DS, et al. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol. 2002;90:124–32.
Edwards DG, Schofield RS, Lennon SL, et al. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol. 2004;93:617–20.
Moore BE, Rothschild AJ. Treatment of antidepressant-induced sexual dysfunction. Hosp Pract. 1999;34:89–96.
Sadovsky R. Selecting patients appropriate for treatment. J Fam Pract 2005; Suppl 5–14.
Data on File, IMS Eli Lilly and Company 2007.
Bosshardt RJ, Farwerk R, Sikora R, et al. Objective measurement of the effectiveness, therapeutic success, and dynamic mechanisms of the vacuum device. Br J Urol. 1995;75:786–91.
Greiner KA, Weigel JW. Erectile dysfunction. Am Fam Phys. 1996;54:1675–82.
Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992;326:90–4.
Helstrom WJG. Management recommendations for family physicians. J Fam Pract 2005; Suppl: 32–40.
Jiann BP, Yu CC, Su CC, Tsai JY. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it. Int J Impot Res. 2006;18(2):146–9.
Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. IJIR. 2002;14(6):466–71.
Montorsi F, Burnett AL. Erectile dysfunction after radical prostatectomy. BJU Int. 2004;93:404–10.
Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int. 2005;95:257–80.
Nusbaum MR. Therapeutic options for patients returning to sexual activity. J Am Osteopath Assoc. 2004;104(3 Suppl 4):S2–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Miner, M., Rajfer, J. (2012). Primary Care Evaluation and Treatment of Erectile Dysfunction. In: Shoskes, D. (eds) Urological Men’s Health. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-900-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-900-6_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-899-3
Online ISBN: 978-1-61779-900-6
eBook Packages: MedicineMedicine (R0)